| Night shift schedule causes circadian dysregulation of DNA repair genes and elevated DNA damage in humans BSC Koritala, KI Porter, OA Arshad, RP Gajula, HD Mitchell, T Arman, ... Journal of pineal research 70 (3), e12726, 2021 | 56 | 2021 |
| Microcystin toxicokinetics, molecular toxicology, and pathophysiology in preclinical rodent models and humans T Arman, JD Clarke Toxins 13 (8), 537, 2021 | 42 | 2021 |
| Sub-chronic microcystin-LR liver toxicity in preexisting diet-induced nonalcoholic steatohepatitis in rats T Arman, KD Lynch, ML Montonye, M Goedken, JD Clarke Toxins 11 (7), 398, 2019 | 27 | 2019 |
| Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity JD Clarke, A Dzierlenga, T Arman, E Toth, H Li, KD Lynch, DD Tian, ... Toxicon 162, 1-8, 2019 | 17 | 2019 |
| Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet T Arman, KD Lynch, M Goedken, JD Clarke Chemosphere 269, 128773, 2021 | 10 | 2021 |
| A pharmacokinetic natural product-disease-drug interaction: a double hit of silymarin and nonalcoholic steatohepatitis on hepatic transporters in a rat model ML Montonye, DD Tian, T Arman, KD Lynch, B Hagenbuch, MF Paine, ... Journal of Pharmacology and Experimental Therapeutics 371 (2), 385-393, 2019 | 10 | 2019 |
| Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin‐drug interactions KD Lynch, ML Montonye, DD Tian, T Arman, VO Oyanna, BJ Bechtold, ... Phytotherapy Research 35 (6), 3286-3297, 2021 | 7 | 2021 |
| MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period T Arman, JA Baron, KD Lynch, LA White, J Aldan, JD Clarke Toxicology 464, 153021, 2021 | 6 | 2021 |
| Endocrine and paracrine characteristics of neuroendocrine prostate cancer T Arman, PS Nelson Frontiers in Endocrinology 13, 1012005, 2022 | 5 | 2022 |
| Abstract C056: Characterization of prostate cancer secretomes for therapeutic intervention T Arman, LA Jones, IM Coleman, PR Gafken, PS Nelson NaN, C056-C056, 2023 | | 2023 |
| Microcystin-LR Hepatic and Renal Toxicity in Nonalcoholic Fatty Liver Disease T Arman Washington State University, 2021 | | 2021 |
| A Pharmacokinetic natural product-disease-drug interaction: a double-hit on hepatic transporters J Clarke, T Arman, M Paine, M Gastecki Drug Metabolism and Pharmacokinetics 34 (1), S67-S68, 2019 | | 2019 |
